SB 6127
Effective date 1/1/2025
Increasing access to human immunodeficiency virus postexposure prophylaxis drugs or therapies.
- Washington
- Senate
- Introduced Jan 10, 2024
- Session 2023-2024
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
Washington’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
28 actions-
Effective date 1/1/2025.
-
Chapter 251, 2024 Laws.
-
Governor signed.
-
Delivered to Governor.
-
Speaker signed.
-
President signed.
-
Passed final passage; yeas, 48; nays, 0; absent, 0; excused, 1.
-
Senate concurred in House amendments.
-
Third reading, passed; yeas, 95; nays, 0; absent, 0; excused, 3.
-
Rules suspended. Placed on Third Reading.
-
Committee amendment(s) adopted with no other amendments.
-
Rules Committee relieved of further consideration. Placed on second reading.
-
Referred to Rules 2 Review.
-
HCW - Majority; do pass with amendment(s).
-
Executive action taken in the House Committee on Health Care & Wellness at 1:30 PM.
-
Executive session scheduled, but no action was taken in the House Committee on Health Care & Wellness at 8:00 AM.
-
Public hearing in the House Committee on Health Care & Wellness at 1:30 PM.
-
First reading, referred to Health Care & Wellness.
-
Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.
-
Rules suspended. Placed on Third Reading.
-
Floor amendment(s) adopted.
-
1st substitute bill substituted (HLTC 24).
-
Placed on second reading by Rules Committee.
-
Passed to Rules Committee for second reading.
-
HLTC - Majority; 1st substitute bill be substituted, do pass.
-
Executive action taken in the Senate Committee on Health & Long Term Care at 8:00 AM.
-
Public hearing in the Senate Committee on Health & Long Term Care at 10:30 AM.
-
First reading, referred to Health & Long Term Care.